Moody Lynn & Lieberson, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Moody Lynn & Lieberson, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$58.38 - $84.96 $291,900 - $424,799	-5,000 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$43.82 - $85.37 $219,100 - $426,850	5,000 New	5,000 $384,000
Q1 2020 Apr 30, 2020	SELL	$20.56 - $63.12 $1.65 Million - $5.08 Million	-80,450 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$28.14 - $73.01 $399,588 - $1.04 Million	14,200 Added 21.43%	80,450 $5.1 Million
Q3 2019 Oct 28, 2019	BUY	$26.26 - $34.86 $1.74 Million - $2.31 Million	66,250 New	66,250 $1.87 Million

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.